Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Absolute Mortality Risk Assessment of Covid-19 Patients: The Khorshid Covid Cohort (Kcc) Study Publisher Pubmed



Marateb HR1, 2 ; Von Cube M3 ; Sami R4 ; Haghjooy Javanmard S5 ; Mansourian M2, 6 ; Amra B7 ; Soltaninejad F8 ; Mortazavi M9 ; Adibi P10 ; Khademi N11 ; Sadat Hosseini N11 ; Toghyani A11 ; Hassannejad R12 ; Mananas MA2, 13 Show All Authors
Authors
  1. Marateb HR1, 2
  2. Von Cube M3
  3. Sami R4
  4. Haghjooy Javanmard S5
  5. Mansourian M2, 6
  6. Amra B7
  7. Soltaninejad F8
  8. Mortazavi M9
  9. Adibi P10
  10. Khademi N11
  11. Sadat Hosseini N11
  12. Toghyani A11
  13. Hassannejad R12
  14. Mananas MA2, 13
  15. Binder H3
  16. Wolkewitz M3
Show Affiliations
Authors Affiliations
  1. 1. Biomedical Engineering Department, Engineering Faculty, University of Isfahan, Isfahan, Iran
  2. 2. Biomedical Engineering Research Centre (CREB), Automatic Control Department (ESAII), Universitat Politecnica de Catalunya-Barcelona Tech (UPC)Building H, Floor 4, Av. Diagonal 647, Barcelona, 08028, Spain
  3. 3. Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
  4. 4. Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  6. 6. Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
  7. 7. Bamdad Respiratory Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  8. 8. The Respiratory Research Center, Pulmonary Division, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  9. 9. Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  10. 10. Isfahan Gastroenterology and Hepatology Research Center (lGHRC), Isfahan University of Medical Sciences, Isfahan, Iran
  11. 11. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  12. 12. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  13. 13. Biomedical Research Networking Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), Madrid, Spain

Source: BMC Medical Research Methodology Published:2021


Abstract

Background: Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. Methods: We used the hospital-based open Khorshid COVID Cohort (KCC) study with 630 COVID-19 patients from Isfahan, Iran. Competing risk methods are used to develop a death risk chart based on the following variables, which can simply be measured at hospital admission: sex, age, hypertension, oxygen saturation, and Charlson Comorbidity Index. The area under the receiver operator curve was used to assess accuracy concerning discrimination between patients discharged alive and dead. Results: Cause-specific hazard regression models show that these baseline variables are associated with both death, and discharge hazards. The risk chart reflects the combined results of the two cause-specific hazard regression models. The proposed risk assessment method had a very good accuracy (AUC = 0.872 [CI 95%: 0.835–0.910]). Conclusions: This study aims to improve and validate a personalized mortality risk calculator based on hospitalized COVID-19 patients. The risk assessment of patient mortality provides physicians with additional guidance for making tough decisions. © 2021, The Author(s).
Other Related Docs